Decompression vs. Fusion Surgery for Spinal Wear
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial compares two surgical options for treating lower spine issues caused by past fusion surgery: decompression surgery alone and decompression with additional fusion (extension fusion). The goal is to determine which method is more effective for individuals experiencing pain or issues in their lumbar spine after previous fusion surgery. Participants must have undergone lumbar fusion surgery at least a year ago and continue to experience symptoms unresponsive to other treatments. Identifying the most effective surgical option can enhance future care for those with spinal problems post-fusion surgery. As a Phase 2 trial, this research measures the effectiveness of each surgical option in an initial, smaller group, allowing participants to contribute to advancements in spinal care.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
A previous study found decompression surgery to be safe for most patients. Research shows that spinal decompression works well in 71% to 89% of cases, with no major issues like spinal instability over two years, indicating that most patients tolerate it well.
For decompression with fusion, studies suggest effectiveness, but some risks exist. These risks include the possibility of needing additional surgery due to issues with surgical hardware or problems in adjacent spine areas. However, fusion techniques often succeed, with some methods proving over 90% effective.
Both decompression alone and with fusion have specific safety considerations. Patients should consult their doctors to determine the best option for their condition.12345Why are researchers excited about this trial?
Researchers are excited about decompression surgery for spinal wear because it offers a less invasive option compared to the traditional fusion surgery. Unlike fusion, which involves permanently joining two or more vertebrae together, decompression surgery focuses on relieving pressure on the spinal cord or nerves without altering the spine's structure dramatically. This can potentially lead to quicker recovery times and reduced risk of complications, making it an attractive option for both patients and doctors seeking effective pain relief and improved mobility.
What evidence suggests that this trial's treatments could be effective for spinal wear?
This trial will compare decompression surgery alone with decompression combined with extension fusion surgery. Studies have shown that decompression surgery can relieve symptoms of lumbar spinal stenosis, a narrowing of the spinal canal. However, long-term issues might still occur in about 90% of patients. Another study found that adding fusion surgery, which involves joining two or more bones in the spine, to decompression surgery can provide similar results to decompression alone, even with degenerative spondylolisthesis, where one vertebra slips over another.
Fusion surgeries have successfully reduced problems in spine segments next to a previous surgery site, known as adjacent segment disease. One study reported a 97% success rate in achieving bone fusion in patients without degeneration, demonstrating strong effectiveness for spinal stability. While both treatments have their benefits, further research is needed to determine which better prevents the need for additional surgeries in the future.56789Who Is on the Research Team?
Daniel Tobert, MD
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
This trial is for adults who've had lumbar fusion surgery involving L2 to the sacrum and are experiencing symptoms at the level above their fusion despite six weeks of non-surgical treatment. They should be at least one year post-op from a previous instrumented posterior lumbar fusion. Those with uninstrumented fusions, trauma, tumors, infections at the adjacent segment, prior pelvic fixations or instability won't qualify.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either decompression alone or decompression with extension of fusion for lumbar adjacent segment disease
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of post-operative narcotic utilization, pain intensity, anxiety, depression, and global health
What Are the Treatments Tested in This Trial?
Interventions
- Decompression
- Extension Fusion
Decompression is already approved in European Union, United States, Canada for the following indications:
- Lumbar spinal stenosis
- Degenerative spondylolisthesis
- Adjacent segment disease
- Lumbar spinal stenosis
- Degenerative spondylolisthesis
- Adjacent segment disease
- Lumbar spinal stenosis
- Degenerative spondylolisthesis
- Adjacent segment disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor